L-Lpharma SRL
L-Lpharma reported total assets of €1.32m at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
The score of L-Lpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +55 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
L-Lpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 23 Oct 2023
- Year ended 31 Dec 2021filed on 10 Oct 2022
L-Lpharma's financial analysis
- Solvency45.0%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of L-Lpharma
L-Lpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0666.963.585
- VAT number
- BE0666963585
- Peppol
- Registered · 0208:0666963585 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Dec 2016
- Registered office
- 2350 Vosselaar
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
L-Lpharma (SRL) has been based in Vosselaar since 2016, active in: activities of holding companies. For 2025, it reports a net profit of 128,582 € and equity of 593,621 €; its revenue is not published. Its solvency stands at 45.0%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to L-Lpharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmada Activities of holding companies Ternat · balance sheet €1.34m
- Delmac Activities of holding companies Gavere · balance sheet €1.30m
- Den Zavelput Activities of holding companies Ronse · balance sheet €1.35m
- La Ricetta Activities of holding companies Asse · balance sheet €1.38m
- P&L10 Activities of holding companies Molenbeek-Saint-Jean · balance sheet €1.38m
- Project Materials Activities of holding companies Huldenberg · balance sheet €1.38m
- AMHE Activities of holding companies Waregem · balance sheet €1.26m
- Immo S.B.M. Partners Activities of holding companies Ternat · balance sheet €1.32m
Frequently asked questions about L-Lpharma
What is the revenue of L-Lpharma?
L-Lpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of L-Lpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0666963585 for L-Lpharma, if the company is VAT-registered. Its company number (CBE) is 0666.963.585.
Where is the registered office of L-Lpharma?
According to the CBE register, the registered office of L-Lpharma is in 2350 Vosselaar.
What is the equity of L-Lpharma?
At the close of the 2025 financial year, the equity of L-Lpharma amounts to 593,621 €, a solvency of 45.0% of total assets.
Who manages L-Lpharma?
The register lists 1 active mandates at L-Lpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of L-Lpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →